Your compound deserves every chance to succeed. But when your endpoints require medical imaging, risks are increased. Does your team have the experience needed to meet the scrutiny of regulatory review?
Rely on Calyx’s Scientific experts to drive the success of your development program. With experience from 2,600+ imaging studies and having supported over 250 new drug approvals – including half of the recently approved oncology treatments designated as Breakthrough Therapies – Calyx can help you design and implement an imaging strategy that gets your compound across the finish line. Faster.